Indian stock markets weekly review - The week that was!

Share |

Thanks for visiting LiveBombayStockExchange.blogspot.in

Here is detailed weekly review of Indian stock markets and overall investor sentiments:

This week (18/8/2014 - 22/8/2014) was good for Indian stock markets as benchmark Stock market index SENSEX and NIFTY moved up by over 1 percent resp, Bank proved most helpful in this rally for the benchmark indices.

NSE's Nifty ended the week up by 1.6 percent while Bombay Stock Exchange's Sensex moved higher by 1.2 percent in the week. Banking stocks helped stock indices in this week's rally. Those who invested in CNX PSU index got a ROI of 6.7 percent.

Detailed Weekly introspection of Indian stock markets:



Banking sector gained the most in this week especially the PSU banks as proposed banking reforms and a dip in global crude oil prices boosted investor sentiment, While PM's independence day speech might not have too much effect on majority investor sentiment, but it did inspire niche investors somewhat.

Other big news for the week was Finance Ministry approval for creating a holding company structure for public sector banks. This holding company will raise money in order to recapitalise public sector banks. As a result UBI, PNB and SBI surged 4-8.1 percent during the 5 sessions.

Oil & gas sector has some news which would make them smile as Oil and Gas index rallied 2 percent this week and would surely rally further as under recovery on diesel retailing dropped to record low of Rs 1.31 per litre after this month's diesel price hike. Hence it would rise further till diesel price becomes market regulated and not subsidized. Crude oil prices fell below USD 100-a-barrel as Libya increased it's oil output and worries over supply from key producer Iraq eased.

Another sector which gained in this week was Pharma sector as Pharma index gained 5.3 percent as almost all of the pharma companies gained. Lupin, Cipla Glenmark touched their all time high rate in this week. Glenmark Pharma gained as it entered in oncology with discovery and initiation of an innovative bispecific antibody-GBR 1302 molecule.

HAPPY TRADING!!